FDA recall D-1595-2014

Bristol-Meyers Squibb · Class I · drug

Product

COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96

Reason for recall

Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials

Distribution

Nationwide, Canada

Key facts

Status
Terminated
Initiation date
2014-05-12
Report date
2014-09-24
Termination date
2015-05-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1595-2014